More importantly, we found that the causal effect of ISI on MASLD was independent of BMI, which means the effects of GLP-1R-based agonists on MASLD were partly independent of their weight-loss effect
If you're taking insulin or sulfonylureas, discuss glucose monitoring and potential dose adjustments
To view a copy of this license, visit About this article Cite this article Holst, J
Around 65% of people taking the highest dose of retatrutide also achieved a BMI of less than 30, which falls under the threshold for obesity, at 80 weeks
Handling & Format GLP3-R is typically supplied as a lyophilized powder to support stability during storage and transport
A nearly 25% average weight reduction in less than a year is unprecedented in the published literature